Welcome!

News Feed Item

Prism Medical Reports Fourth Quarter and Fiscal 2013 Results

TORONTO, ONTARIO -- (Marketwired) -- 03/25/14 -- Prism Medical Ltd. ("Prism Medical" or "the Company") (TSX VENTURE: PM), a leading provider of durable medical equipment and related services to the mobility challenged, today reported financial results for the fourth quarter (Q4) and fiscal year ended November 30, 2013.

Financial Summary


                                    Three months ended           Year ended
(in thousands of Canadian dollars)         November 30          November 30
----------------------------------------------------------------------------
                                        2013      2012       2013      2012
                                           $         $          $         $
----------------------------------------------------------------------------
Revenues                              20,423    18,270     75,823    76,027
Gross margin                           8,958     6,435     30,803    29,193
  (as % of revenues)                    43.9%     35.2%      40.6%     38.4%

Net income (loss)                      1,781      (142)     4,471     2,275
  (as % of revenues)                     8.7%     (0.8%)      5.9%      3.0%

Adjusted EBITDA                        3,318       671     10,534     6,514
  (as % of revenues)                    16.2%      3.7%      13.9%      8.6%

Earnings (loss) per share
  Basic                                 0.21     (0.02)      0.53      0.27
  Diluted                               0.21     (0.02)      0.53      0.27
----------------------------------------------------------------------------
----------------------------------------------------------------------------

Q4 and Fiscal Year 2013 Highlight:


--  We achieved a record EBITDA performance for the year;
--  Gross margin rate of 43.9% for the quarter is a significant improvement
    over prior quarters;
--  The MedCare supply agreement is performing in line with expectations;
--  SG&A costs are in line with expectations and well below prior year
    levels;
--  Earnings per share for the year increased from $0.27 to $0.53;
--  Cash provided by operating activities decreased from $7,291 in fiscal
    2012 to $5,765 in part as a result of the MedCare transaction;
--  Four dividends of $0.08 per share have been paid this fiscal year.

Financial Review

Revenues for the three months and twelve months ended November 30, 2013 increased by $2,153 or 11.8% and decreased $204 or 0.3% respectively. Details below:

United Kingdom (UK)

Revenues for the three months ended November 30, 2013 increased $371 or 3.4% over the same period last year. Revenues for the year ended November 30, 2013 decreased $1,167 or 2.8% versus last year. The prior year included the positive impact of sales from the Leonard Cheshire contract which did not continue in 2013 causing the year's shortfall in sales. The small 3.4% increase in comparable fourth quarter sales reflects the modest gains made in a tight market due to reduced government expenditures. New products introduced in the 4th quarter and the successful development of new European dealers should positively affect sales in 2014.

United States (US)

For the three months ended November 30, 2013, US revenues increased $1,267 or 31.4% versus the same period last year. For the year ended November 30, 2013, revenues increased $5,077 or 28.7% versus the same period last year. This growth has been caused by MedCare sales, increased independent homecare dealers and additional contracts with substantial acute care facilities.

In December 2012, the beginning of the 2013 fiscal year, the Company acquired the manufacturing assets of MedCare. As part of the transaction, the Company entered into a 10-year agreement to exclusively supply all the products MedCare sells in the moving and handling industry and purchased 49% of the Company. MedCare's operations are based in Minneapolis, Minnesota, USA. The company's product offering will expand with the acquisition of the MedCare product ranges which the Company intends to market in other world geographies. In addition, the Company will leverage MedCare's strong base of dealer business in the long-term care sector and continue to build the hospital group customer base in new geographies with the inclusion of several world-renowned hospital groups. Subsequent to year end, the Company acquired the remaining 51% of MedCare.

Canada

For the 3 months ended November 2013, sales increased 16% versus the same period in the previous year, reversing the decline experienced in the first 3 quarters of fiscal 2013. This increase was driven by a market wide uptick in the acute care market, in particular in Eastern Canada and Ontario. Government spending is still restrained but some new facilities are being funded and built, largely to meet the ongoing demand fueled by the aging baby boom demographics. Revenues for the year ended November 30, 2013 decreased $4,114 or 24.3% reflecting tighter provincial budgetary spending on a comparative basis, particularly in B.C. where in the first half of fiscal 2012, we received a large end-of-life replacement order.

Gross margin

For the quarter ended November 30, 2013, gross margin increased $2,523 or 39.2% compared to the same period last year. For the year ended November 30, 2013, gross margin increased $1,610 or 5.5% compared to the same periods last year. As a percentage of revenues, gross margin increased from 35.2% to 43.9% in the quarter and from 38.4% to 40.6% for the year ended November 30, 2013. Margin improvements for the year were driven by MedCare sales, greater efficiency in the provision of installation services, more favourable product mix and considerable cost reductions in fixed UK overheads partially offset by higher research and development spending. In the last quarter, the more substantial margin percentage of sales increase was also affected by a much higher utilization of North American fixed overheads.

Expenses

Selling, general and administrative expenses for the three months and year ended November 30, 2013 increased by $189 or 2.9% and decreased by $1,554 or 6.1% respectively compared to the same periods last year. The increase in SG&A in the fourth quarter relates to costs associated with various strategic initiatives. On a year to date basis, SG&A costs have decreased as a percentage of sales, reflecting restructuring initiatives taken in 2012.

Interest expense was significantly higher in the three months and year ended November 30, 2013 compared with the same period last year due to the utilization of the acquisition line for our investment in MedCare.

Net Income

Net Income for the three months ended November 30, 2013 increased $1,923 compared to a loss of $142 in the three months ended November 30, 2012. For the year ended November 30, 2013, net income increased $2,196 or 97% compared to net income of $2,275 for the year ended November 30, 2012.

Adjusted EBITDA

For the three months and year ended November 30, 2013, adjusted EBITDA increased $2,647 or 394% to $3,318 and $4,020 or 62% to $10,534 respectively compared to the same periods last year.

Outlook

Prism intends to grow sales, profitability and return on shareholders' equity. The Company believes that performance will be positively affected by continued North American institutional demand for our products, improved manufacturing efficiencies, greater geographic coverage, and revenues and profits from new product introductions. Through additional distribution, both through independent dealers and Company-owned platforms and MedCare, Prism hopes to achieve continued growth in UK and North American profitability even with the ongoing uncertain economic environment.

The demand for our core products and services, in management's estimation, continues to experience growth at different rates in the geographic markets in which we participate. Government funding for our products, particularly in Canada and the UK is a key driver of sales. Although government policies related to health care in the markets in which we operate continues to change, we believe that our ability to deliver cost effective solutions to the health care providers combined with the aging demographics, mean the long term trends continue to be favorable.

In the Company's view, the US market holds the greatest long-term potential to provide above-average revenue growth. Institutional penetration for safe patient moving and handling equipment is well below what is witnessed in mature markets such as the UK and the homecare market is similarly underdeveloped. While budget constraints and the cyclicality of the institutional order pipeline can cause variability in the timing of US revenues, our customers are committed to creating safe patient handling environments in their facilities. Our efforts to build a larger footprint in this market have already translated into strong revenue growth. Additionally Prism is actively growing its dealer footprint in the US and designing affordable products for the private-pay home care market.

About Prism Medical Ltd.

Prism Medical Ltd. is one of the largest providers and manufacturers of durable medical equipment and related services to the mobility challenged in Canada, the US and the UK, with more than 110,000 installations and 200,000 product solutions sold. The Prism Medical brands include Waverley Glen and ErgoSafe, North America's leading supplier of lifting, handling and repositioning aid products and services across Canada and the US. Freeway and Prism Service & Repair are leading suppliers of moving and handling products and services in the UK. For further information visit Prism Medical's website at www.prismmedicalltd.com or www.sedar.com.

(1) Non-IFRS Financial Measures

Prism Medical's consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS). The Company also uses non-IFRS measures such as Adjusted EBITDA to measure its financial performance. Adjusted EBITDA consists of earnings before interest, income taxes, depreciation, amortization, stock-based compensation expense and equity gains or losses from investments in associates accounted on an equity basis. Adjusted EBITDA is a financial metric used by many investors to compare companies on the basis of operating results, asset value and the ability to incur and service debt. Management believes that Adjusted EBITDA is a useful measure for evaluating the performance of the Company. Adjusted EBITDA is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS and may not be comparable to similarly titled financial metrics reported by other companies.

Forward-Looking Information

This document contains forward-looking statements relating to our operations and to the environment in which we operate and our strategy, action plans and investments, which may involve estimates, forecasts and projections. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict and/or are beyond our control. A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. These factors include those set forth in this report and our other public filings. Consequently, readers should not place any undue reliance on such forward-looking statements. These forward-looking statements are made as of the date of this report. Prism Medical is under no obligation to update any forward-looking statements contained herein should material facts change due to new information, future events or other factors. All forward-looking statements attributable to Prism Medical are expressly qualified by these cautionary statements.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contacts:
Prism Medical Ltd.
George Chiarucci
Chief Financial Officer
416-260-2145 ext. 229
gchiarucci@prismmedicalltd.com
www.prismmedicalltd.com

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
Cognitive Computing is becoming the foundation for a new generation of solutions that have the potential to transform business. Unlike traditional approaches to building solutions, a cognitive computing approach allows the data to help determine the way applications are designed. This contrasts with conventional software development that begins with defining logic based on the current way a business operates. In her session at 18th Cloud Expo, Judith S. Hurwitz, President and CEO of Hurwitz & ...
910Telecom exhibited at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. Housed in the classic Denver Gas & Electric Building, 910 15th St., 910Telecom is a carrier-neutral telecom hotel located in the heart of Denver. Adjacent to CenturyLink, AT&T, and Denver Main, 910Telecom offers connectivity to all major carriers, Internet service providers, Internet backbones and exchanges.
Whether you like it or not, DevOps is on track for a remarkable alliance with security. The SEC didn’t approve the merger. And your boss hasn’t heard anything about it. Yet, this unruly triumvirate will soon dominate and deliver DevSecOps faster, cheaper, better, and on an unprecedented scale. In his session at DevOps Summit, Frank Bunger, VP of Customer Success at ScriptRock, discussed how this cathartic moment will propel the DevOps movement from such stuff as dreams are made on to a practic...
As software becomes more and more complex, we, as software developers, have been splitting up our code into smaller and smaller components. This is also true for the environment in which we run our code: going from bare metal, to VMs to the modern-day Cloud Native world of containers, schedulers and micro services. While we have figured out how to run containerized applications in the cloud using schedulers, we've yet to come up with a good solution to bridge the gap between getting your contain...
The modern software development landscape consists of best practices and tools that allow teams to deliver software in a near-continuous manner. By adopting a culture of automation, measurement and sharing, the time to ship code has been greatly reduced, allowing for shorter release cycles and quicker feedback from customers and users. Still, with all of these tools and methods, how can teams stay on top of what is taking place across their infrastructure and codebase? Hopping between services a...
Niagara Networks exhibited at the 19th International Cloud Expo, which took place at the Santa Clara Convention Center in Santa Clara, CA, in November 2016. Niagara Networks offers the highest port-density systems, and the most complete Next-Generation Network Visibility systems including Network Packet Brokers, Bypass Switches, and Network TAPs.
Zerto exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016. Zerto is committed to keeping enterprise and cloud IT running 24/7 by providing innovative, simple, reliable and scalable business continuity software solutions. Through the Zerto Cloud Continuity Platform™, organizations can seamlessly move and protect virtualized workloads between public, private and hybrid clouds. The company’s flagship product, Zerto Virtual...
WebRTC is about the data channel as much as about video and audio conferencing. However, basically all commercial WebRTC applications have been built with a focus on audio and video. The handling of “data” has been limited to text chat and file download – all other data sharing seems to end with screensharing. What is holding back a more intensive use of peer-to-peer data? In her session at @ThingsExpo, Dr Silvia Pfeiffer, WebRTC Applications Team Lead at National ICT Australia, looked at differ...
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
For basic one-to-one voice or video calling solutions, WebRTC has proven to be a very powerful technology. Although WebRTC’s core functionality is to provide secure, real-time p2p media streaming, leveraging native platform features and server-side components brings up new communication capabilities for web and native mobile applications, allowing for advanced multi-user use cases such as video broadcasting, conferencing, and media recording.
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
"Plutora provides release and testing environment capabilities to the enterprise," explained Dalibor Siroky, Director and Co-founder of Plutora, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
SYS-CON Events announced today that CA Technologies has been named "Platinum Sponsor" of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, New York, and 21st International Cloud Expo, which will take place in November in Silicon Valley, California.
The security needs of IoT environments require a strong, proven approach to maintain security, trust and privacy in their ecosystem. Assurance and protection of device identity, secure data encryption and authentication are the key security challenges organizations are trying to address when integrating IoT devices. This holds true for IoT applications in a wide range of industries, for example, healthcare, consumer devices, and manufacturing. In his session at @ThingsExpo, Lancen LaChance, vic...